Namenda Buyers' Attys Seek $212M From Allergan Deal
The legal team that steered drug wholesalers to a record-breaking $750 million deal with Allergan PLC over claims its subsidiary thwarted generic competition has requested a $212 million cut of the...To view the full article, register now.
Already a subscriber? Click here to view full article